Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

PhRMA CEO: Ubl Pick Brings User Fee, Reimbursement Expertise

Executive Summary

Steve Ubl has led AdvaMed for 10 years, raising profile of device industry on Capitol Hill and executing well-regarded public relations campaign of the kind the drug industry might need as it enters political maelstrom on pricing.

Advertisement

Related Content

AdvaMed Launches National Search For New CEO As Ubl Plans Departure
PhRMA Will Pursue Future ‘Cures’ Without Castellani: CEO Retiring Jan. 1
Device Industry Amps Up Efforts To Repeal Device Tax In Lame Duck Session
Can Jersey City Be A Cure For What Ails Pharma?
Health Care Reform and the Biopharma Sector: A Complete Tactical Victory
Device Industry Continues Push To Influence Health Care Reform Dialogue
It’s The Economy, Stupid: “Value” Campaign To Stress System-Wide Savings
AdvaMed Escalates Opposition To Inpatient Proposal With Ad Campaign
Device Industry Aims To Prevent Image Problems That Have Plagued Pharma
AdvaMed President Ubl Brings Detailed Policy Approach To Industry Agenda

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

PS057163

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Add a personalized Question to your Analyst

Cancel